Navigation Links
Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
Date:9/14/2007

READING, Pa., Sept. 14 /PRNewswire-FirstCall/ -- Arrow International, Inc. (Nasdaq: ARRO) today reported that Proxy Governance, Inc. a leading independent proxy voting advisory firm, has advised its clients to vote to approve Arrow's planned $45.50 merger with Teleflex Incorporated (NYSE: TFX) and for the re-election of Arrow's current Board of Directors at the Annual Meeting of Arrow shareholders on September 20, 2007.

Proxy Governance is the fourth proxy advisory firm to recommend a vote for the merger agreement. On September 7, as previously reported, Glass, Lewis & Co. recommended that Arrow shareholders vote to approve the merger agreement with Teleflex and for the election of all of the Arrow director nominees. On September 12, Egan Jones also recommended its clients support the merger and the re-election of the full Arrow Board of Directors and Institutional Shareholders Services (ISS) recommended its clients approve the merger and support the election of a majority of the current Board of Directors.

R. James Macaleer, Chairman commented, "We are pleased with the universal support for the Teleflex merger that we have received from four leading proxy advisory firms. We are also pleased that Glass Lewis, Proxy Governance, and Egan Jones also support the re-election of the full Board of Directors. However, we think that ISS is introducing unnecessary uncertainty into the voting process by recommending that shareholders support two McNeil Trust nominees and withhold votes from five McNeil Trust nominees. We believe that any change in the composition of the Board at this point could be detrimental to the timely completion of the Teleflex merger. We strongly believe that shareholders will benefit by voting for all of Arrow's director nominees. This Board is fully committed to completing the Teleflex transaction and acting in the best interests of all shareholders."

Arrow shareholders are reminded to vote the WHITE proxy card today to support the merger agreement with Teleflex and the election of the full slate of Arrow director nominees who will manage any events which may arise following the Annual Meeting and prior to the consummation of the merger. Arrow shareholders are cautioned NOT to return a blue proxy to the McNeil Trust.

All votes are important. For shares held by a brokerage firm or bank, Arrow shareholders should provide them with instructions on how to vote or they will be unable to vote on certain issues, including the adoption of the merger agreement. Please return the WHITE proxy card to the broker or bank to ensure that shares are voted or vote by telephone or Internet.

Shareholders with questions regarding the solicitation may contact Arrow International's proxy solicitor, Morrow & Co., Inc. toll-free at 1-800-662-5200.

About Arrow

Arrow develops, manufactures and markets a broad range of clinically advanced, disposable catheters and related products for critical and cardiac care. The company's products are used primarily by anesthesiologists, critical care specialists, surgeons, emergency and trauma physicians, cardiologists, interventional radiologists and other healthcare providers. Arrow's news releases and other company information can be found on the World Wide Web at http://www.arrowintl.com. Arrow's common stock trades on the NASDAQ Global Select Market(TM) under the symbol ARRO.

Additional Information

In connection with the proposed acquisition of Arrow by Teleflex Incorporated and Arrow's 2007 Annual Meeting of Shareholders, Arrow filed a definitive proxy statement with the SEC, on August 24, 2007 and will be filing other documents with the SEC. Arrow has furnished a definitive proxy statement to its shareholders, together with a WHITE proxy card. Arrow shareholders are strongly advised to carefully read Arrow's definitive proxy statement. Shareholders may obtain the definitive proxy statement on file with the SEC and any other documents filed by Arrow with the SEC for free at the internet website maintained by the SEC at http://www.sec.gov. Shareholders may obtain free copies of the definitive proxy statement and any amendments and supplements to the definitive proxy statement at Arrow's website at http://www.arrowintl.com or by writing to Arrow International, Inc., 2400 Bernville Road, Reading, Pennsylvania 19605. In addition, copies of Arrow's proxy materials may be requested by contacting our proxy solicitor, Morrow & Co. at (800) 662-5200 toll-free or by writing to Morrow & Co., 470 West Avenue, Stamford, CT 06902. Arrow and its directors and executive officers may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. Additional information regarding the names, affiliations and interests of individuals who are participants in the solicitation of proxies of Arrow's shareholders is available in Arrow's definitive proxy statement filed with the SEC on August 24, 2007.


'/>"/>
SOURCE Arrow International, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Delhi Government To Interlink All Major Hospitals Through e-Governance
2. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
3. Rat joins list of cloned animals
4. Richard Gere Joins Indian Stars For Fight Against AIDS
5. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
6. Anoushka Joins Hands With WFP to Feed the Poor
7. India Joins Hands With Global Body for Vaccine Research
8. Another Statewide Organization Joins the Fight Against Assisted Suicide
9. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
10. Short Glasses Make You Drink More
11. Over indulgence more so when intake is in short glasses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... , ... CURE Media Group , the nation’s leading digital and print ... Awards event , which will annually honor individuals making heroic contributions in the field ... MM Heroes Awards nomination process is officially open through February 17 for patients, ...
(Date:2/8/2016)... PA (PRWEB) , ... February 08, 2016 , ... ... expanded authorization with BASF Human Nutrition into the Food & Beverage ... BSI has been BASF’s channel partner throughout Canada and USA geographies east of ...
(Date:2/8/2016)... Houma, LA (PRWEB) , ... February 08, 2016 ... ... Louisiana from offices in Houma, LA, celebrates the beginning of a new charity ... raised to assist Court Appointed Special Advocates (CASA). In the belief that children ...
(Date:2/8/2016)... ... ... man who has struggled to quit smoking, a man who has struggled with hair loss ... to his problems – and he did. Now Nabat, a serial entrepreneur featured as the ... inventions to the world and better people's lives. His own experience with nicotine addiction led ...
(Date:2/8/2016)... ... ... If you are feeling that your clothes are a tad snug, the ... Center for Disease Control and Prevention (CDC), 34.9% of U.S. adult women are overweight. ... some of the leading causes of preventable death. February is heart health month ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... and HONG KONG , Feb. ... Simon Pedder , PhD, has joined Athenex as Vice President ... and Mr. Raymond Yeung , MSc, MBA has joined as ... Asia-Pacific, based in Hong Kong . ... management team that I have known for a while. Coupled ...
(Date:2/9/2016)... , Feb. 9, 2016  Bluestar Silicones will ... product line for long-term implant applications and announce ... Design & Manufacturing (MD&M) West Conference (Booth #1759), ... --> --> Available ... Biomedical LSRs offer outstanding physical properties enabling our ...
(Date:2/8/2016)... , Feb.8, 2016 Cardiac ... Summary GlobalData,s Medical Devices sector report, ... Assessment, 2015 " provides an overview of Cardiac ... report provides comprehensive information on the pipeline products ... stages of development. The report reviews major players ...
Breaking Medicine Technology: